Carregant...
SGLT2 inhibition and kidney protection
Type 2 diabetes mellitus (T2DM) is a growing public health concern worldwide. Numerous drug classes are available for treatment, however, their efficacy with regard to diabetes-induced renal and cardiovascular (CV) complications remains limited. Inhibitors of the sodium-glucose cotransporter 2 (SGLT...
Guardat en:
| Publicat a: | Clin Sci (Lond) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6648703/ https://ncbi.nlm.nih.gov/pubmed/29954951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20171298 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|